🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Bortezomib may stop the growth of myeloma cells by blocking prot...
Status
Unknown
Location
The Second Affiliated Hospital of Soochow University
Start Date
2013-12
Trial ID
NCT02027220
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose and ef...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2008-06
Trial ID
NCT00833833
Treatments Being Tested
This phase II trial studies how well daratumumab, ixazomib, and dexamethaso...
Status
Unknown
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2019-07-03
Trial ID
NCT03942224
Treatments Being Tested
The purpose of this study is to determine the response rate of the combinat...
Status
Completed
Location
Integrated Community Oncology Network
Start Date
2004-09
Trial ID
NCT00789256
Treatments Being Tested
This is a Phase I/II multicenter, open-label, dose-escalation study of ritu...
Status
Completed
Location
Providence Medical Group
Start Date
2008-06
Trial ID
NCT00633594
Treatments Being Tested
It is expected to include 40 patients with M-protein related cardiac diseas...
Status
Unknown
Location
Multiple Locations
Start Date
2024-03-15
Trial ID
NCT06297681
Treatments Being Tested
Participant that has been diagnosed with Relapsed/ Refractory Multiple Myel...
Status
No Longer Available
Location
Dana Farber Cancer Institute
Start Date
TBD
Trial ID
NCT02666209
Treatments Being Tested
RATIONALE: Radioactive drugs, such as samarium Sm 153 lexidronam pentasodiu...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2005-09
Trial ID
NCT00478075
Treatments Being Tested
This is a interventional phase II study aiming to examine the complete resp...
Status
Recruiting
Location
Instituto do Cancer do Estado de Sao Paulo
Start Date
2024-04-01
Trial ID
NCT06034561
Treatments Being Tested
Systemic amyloidoses are rare diseases affecting approximately 1 in 100,000...
Status
Terminated
Location
Cross Cancer Insititue, University of Alberta
Start Date
2019-02-11
Trial ID
NCT03474458
Treatments Being Tested